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The copper-catalysed zinc phosphonate chemistry described by Yokomatsu and Shibuya can be used to enter
the classical organometallic coupling repertoire via Stille and Suzuki–Miyaura couplings. 1,4-Diiodobenzene
underwent coupling with the organozinc reagent derived from diethyl bromodiﬂuoromethylphosphonate with
copper() catalysis to aﬀord diethyl (4-iodophenyl)diﬂuoromethylphosphonate. Higher yielding couplings were run
with (4-triﬂuoromethylsulfonyloxy)- and (4-nonaﬂuorobutylsulfonyloxy)-iodobenzenes. The iodide and the triﬂate
coupled under palladium-catalysed conditions with a range of stannanes and boronic acids in moderate to excellent
yields. Shibuya–Yokomatsu couplings were also successful with more functionalised iodoarenes and heteroarenes
presenting the important phosphate mimic on a range of scaﬀolds.
Non-hydrolysable phosphotyrosine mimics including (diﬂuoro-
phosphonomethyl)phenylalanine 1 have aroused the interest
of many groups concerned with the role of transient protein
phosphorylation in disease (notably cancer) and the possible
importance of the process as a target for the development of
new therapeutic agents and strategies.1,2 The current literature
burgeons as (particularly industrial) groups deﬁne the selectiv-
ity of binding events and bases for molecular recognition of
inter alia Grb-2,3–5 Lck SH-2,6,7 Src-SH2,8–12 and p-85 C-SH2 13
receptor sites. The fruitful collaboration between Burke and
Barford has yielded profound insight into small molecule
ligand–large molecule receptor interactions based upon a
number of key crystal structures,14 providing a solid basis for
molecular design of ligands.15 Mimesis responds to a number of
imperatives; as the binding site recognises a tetrahedral phos-
phate monoester dianion within a hydrogen bonding array to
two arginine residues, charge and shape are critical. Diﬂuoro-
phosphonates confer hydrolytic stability while preserving the
correct charge and geometry. Other mimetics were described
recently by Fretz (ArOCF2CO2H)
16 and Burke et al. (ArCF2-
COOH);17 they share the advantage of lower charge (an asset
for potential in vivo applications) but oﬀer diﬀerent geometries
to the recognition array. These mimetics are also straight-
forward to synthesise;18–20 carbene chemistry is eﬀective in the
former case, while the recent coupling approach to the latter
described by Kumadaki 21 and co-workers represents a signiﬁ-
cant advance. Malonates (OMt and FOMt) also have a role to
play and have been eﬀective probes and inhibitors in certain
cases.22,23
Modern methods for the generation of molecular diversity
have not to our knowledge been deployed extensively in this
area of chemistry—the attempts by Ganesan 24 and Bergnes 25
to synthesise libraries of phosphate mimetics as potential
phosphatase inhibitors provide rare examples and illustrate
the need for readily-available functionalised scaﬀolds bearing
phosphate mimetics. Following our recent communication in
this area,26 we wish to describe the scope, generality and limit-
ations of palladium-catalysed coupling reactions investigated in
our laboratory.
As described by Shibuya,27,28 1,4-diiodobenzene underwent
smooth coupling (Scheme 1) to aﬀord the iodophenyl phos-
phonate 2 and bis-coupled 3 which could be separated from
each other, and from homo-coupled 4, by simple column
chromatography. Intermediates such as 2 also present an
opportunity for the generation of molecular diversity through
exploitation of the second carbon–iodine bond in a palladium-
catalysed coupling reaction. Of course, aryl triﬂates are also
accepted in this repertoire of reactions, whereas the Shibuya
coupling does not run for aryl triﬂate substrates thus avoiding
the formation of bis-coupled 3, so we decided to explore the
behaviour of (iodoaryl)perﬂuoroalkanesulfonates under the
Shibuya conditions.
Consistent with the reactivity described by Shibuya, iodotri-
ﬂate 5a, prepared from 4-iodophenol on a 50 g scale under
standard conditions (triﬂic anhydride, pyridine, 0 C, 95%) 29
underwent eﬃcient coupling under sonication conditions to
aﬀord 6a in a pleasing 66% isolated, puriﬁed yield (Scheme 2).
Typically, 2 equivalents of the copper–zinc reagent were used for
these couplings. Intermediate 6a could be stored for extended
periods in the freezer without decomposition. The nonaﬂate
(nonaﬂuorobutanesulfonate) 5b was prepared following a
literature procedure 30 and coupled in a similar way aﬀording
6b in 75% yield. Short periods of sonication were required in
both cases. The more bulky diisopropyl phosphonate 7 could be
Scheme 1 Reagents and conditions: i, BrZnCF2PO(OEt)2, CuBr,
DMA, rt, sonicate 3 hours then 24 hours at rt.
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coupled via the corresponding organozinc reagent with iodotri-
ﬂate under similar conditions to aﬀord 6c though in rather
lower (31%) yield. Table 1 summarises additional results with a
range of aromatic templates. Contrasting results were obtained
when m- and p-iodoanisole were exposed to 1.5 equivalents of
the coupling reagent; educts 8 and 9 were obtained in 32 and
17% yields respectively suggesting that the rate-determining step
in the coupling sequence is oxidative addition of an organo-
metallic reagent into the C–I bond.31 Similar behaviour was
observed in the eﬃcient coupling of activated substrate 12
(67%) derived from commercial 10 (Scheme 3). Substrates 14
and 15 coupled rather sluggishly to aﬀord 16 (25%), and 17a
(19%) and 17b (21%) respectively. In 15, the two C–I bonds
appear rather similar electronically and the two insertions occur
at almost identical rates despite a diﬀerence in steric hindrance.
However, in the original report of the coupling reaction by
Scheme 2 Reagents and conditions: i, BrZnCF2PO(OR)2, CuBr,
DMA, rt, sonicate 3 hours then 24 hours at rt.
Scheme 3 Reagents and conditions: i, BnBr, KF, DMF, rt; ii, Tf2O,
pyridine, 0 C; iii, BrZnCF2PO(OEt)2, CuBr, DMA, rt, sonicate 3 hours
then 24 hours at rt.
Table 1 Shibuya–Yokomatsu couplings on electron-rich, functional-
ised benzenoid and heteroaromatic templates
Template X = I X = CF2PO(OEt)2 Yield (%)
8 32
9 17
14 16 25
15 a 17a b
17b
19
21
18 19 62
20 0
a 15, Y = I. b 17a, X = CF2PO(OEt)2, Y = I; 17b, X = I, Y = CF2PO(OEt)2.
Yokomatsu and co-workers,28 methyl 2-iodo- and 4-iodo-
benzoate coupled in identical (99%) yields suggesting that the
steric hindrance provided, at least, by an sp2 hybridised array, is
minimal. Commercial heteroaryl 2-iodothiophene 18 displayed
the expected high reactivity and underwent Shibuya–Yoko-
matsu coupling to 19 in 62% yield. Coupling failed completely
with 20 in which a benzyloxy group ﬂanks the coupling site and
in which a pyridyl nitrogen is also present. From these results,
we conclude that protection of phenolic hydroxy groups may
be best undertaken using electron withdrawing sulfonate esters
rather than ethers.32
Stille coupling reactions of 2 and 6a with a range of ali-
phatic, aryl and heteroaryl tributylstannanes 21a–h aﬀorded
coupling products 22a–h in moderate to high yields, thus pre-
senting the phosphate mimicking group on a wide range of
biaryl scaﬀolds (Table 2), in clear contrast to the results
reported by the Tokyo group who found the triﬂate an ineﬃ-
cient precursor for coupled products. Coupling conditions were
not optimised exhaustively but our best results were achieved
in hot (60 C) DMF with either Pd(PPh3)2Cl2 (5 mol%) or
Pd2dba3CHCl3 complex (2.5 mol%); tetrakis(triphenyl-
phosphino)palladium(0) and (dppb)PdCl2 were ineﬀective
catalysts for the reaction in our hands. The addition of lithium
chloride to the Stille reactions either inhibited the coupling,
or resulted in decomposition of 2 or 6a. Lower yields were
obtained when couplings were attempted in 1,4-dioxane either
at room temperature or at reﬂux, but Stille couplings with 2
proceeded in moderate yield in THF, suggesting that oxidative
addition is indeed the slow step in the sequence and that nucleo-
philic attack at phosphorus (or elsewhere) competes when this
Table 2 Stille couplings of 6a a
Stannane 21 Time/h Product Yield (%)
21a 5
1
22a 51
84 b
21b 6 (22b) c
23
(–)
52
21c 6 22c 52
21d 6 22d 79
90 d
21e 6 (22e) e
24
60
30 b
21f 1 22f 53
57 b
21g 6 22g 64
21h 6 22h 52
49 b
a 1.0 equiv. 6a, 1.0 equiv. stannane, 5% Pd(PPh3)2Cl2, DMF, 60 C. 
b Yield
from 2 under these conditions. c The methyl ketone 23 was isolated after
hydrolysis. d 5% Pd2dba3CHCl3, 10% CuI, 20% PPh3, DMF, 60 C.
e The aldehyde 24 was isolated after hydrolysis.
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initial step becomes laboured. Triﬂate 6a performed as well as,
if not better than iodide 2 in most cases. Bulkier alkoxy groups
at phosphorus have been used traditionally to solve the problem
of nucleophilic attack but we did not explore this possibility in
view of the success of most of the couplings. Increases in yield
(up to 90% for 21d) were obtained under one set of Farina–
Liebeskind conditions 33 in which copper() iodide (10 mol%)
and Ph3P (20 mol%) were added. We were also able to use 13
eﬃciently in Stille coupling with (tributylstannyl)furan; product
25 was aﬀorded under the CuI–Ph3P conditions in good
(70%) yield. Direct coupling with (trimethylsilyl)ethyne also
proceeded well to aﬀord 26 (80% yield) under the palladium-
catalysed conditions described by Chen and Yang.34
Suzuki coupling conditions were based on the ﬁndings of
Shieh and Carlson.35 For the reaction between 6a and 2,3-
dimethoxyphenylboronic acid, the heterogeneous conditions
(Pd(PPh3)4, K2CO3, PhMe, 90 C) aﬀorded none of the desired
biaryl but the homogeneous conditions which use the same
catalyst and triethylamine base in DMF were more successful
and the biaryl was formed. Table 3 shows the scope of the
chemistry. The acceptable yield of the 4-bromo biaryl 27c is
of note, as is the successful coupling with the alkylboronic
acid in the absence of any activating additive (to form the
ate-complex).
These results show tolerance by the diﬂuoromethyl-
phosphoryl group of non-nucleophilic coupling conditions,
and the availability of aryl phosphonate building blocks of dif-
ferent levels and types of reactivity. These and related species
could be of some use in combinatorial solid and solution phase
approaches to the development of PTK ligands and inhibitors
with in vitro applications at least. The recent publication of a
series of 3-PGK inhibitors by the Sheﬃeld group 36 signiﬁes
continuing interest in the area.
Experimental
All NMR spectra were obtained in CDCl3 and were recorded
relative to tetramethylsilane as the internal standard. 1H and
13C NMR spectra were recorded on a Bruker AC-300 (300.13
and 75.47 MHz respectively) spectrometer. 13C NMR spectra
were recorded using the JMOD pulse sequence. 31P NMR
spectra were also recorded on a Bruker AC-300 (121.50 MHz)
spectrometer using orthophosphoric acid as the internal stand-
ard. 19F NMR spectra were recorded on a Bruker AC-300
(282.41 MHz) relative to chlorotriﬂuoromethane as the internal
standard. Chemical ionisation (CI) and electron impact (EI)
mass spectra were recorded on a VG ProSpec mass spec-
trometer, a Kratos Proﬁle mass spectrometer or a VG Zabspec
mass spectrometer. Chemical ionisation (CI) methods used
ammonia as the reagent gas. LC/MS were performed at
room temperature using an HP1050 HPLC (5 µl injection
volume; 3 µm ABZPLUS column with 3.3 cm × 4.6 mm
internal diameter) and a Platform Series II mass spectrometer.
The HPLC ran a 5.50 minute solvent gradient (time taken to
change from one solvent to another at the quoted ﬂow rate)
from formic acid to 10 mM ammonium nitrate–acetonitrile–
formic acid (10 :85 :5) with a ﬂow rate of 3 ml min1. A Micro-
mass LCT mass spectrometer was used for both low resolution
(ES-TOF) mass spectra and HRMS measurements (using
a lockmass incorporated into the mobile phase). Elemental
analyses were performed at the University of North London.
For TLC, precoated aluminium-backed silica gel plates were
supplied by E. Merck, A.G. Darmstadt, Germany (silica gel 60
F254, thickness 0.2 mm, Art. 5554). Visualisation was achieved
by UV light and/or an anisaldehyde–sulfuric acid or potassium
permanganate stain. Flash column chromatography was per-
formed using an air compressor on silica gel (E. Merck A.G.
Kieselgel 60, Art. 9385). THF was dried by reﬂuxing with
benzophenone over sodium wire until a deep purple colour
developed, then distilled and collected by dry syringe as
required. Dimethylacetamide (DMA) was dried overnight with
barium oxide then distilled under reduced pressure, and the
distillate stored over calcium hydride under an atmosphere
of nitrogen. Diisopropylamine and triethylamine were distilled
from calcium hydride and each stored under an atmosphere
of nitrogen over calcium hydride. Dimethylformamide was dis-
tilled from calcium hydride and stored over 4 Å molecular
sieves under an atmosphere of nitrogen.
Tetrakis(triphenylphosphino)palladium(0) and bis(triphenyl-
phosphino)palladium() chloride were used as supplied by the
Aldrich Chemical Co. Ltd. Zinc activation was achieved by
heating the desired quantity of Aldrich 325 mesh zinc dust to
260 C under vacuum (0.01 mmHg) for two hours. Sonication
reactions were performed using a Kerry BE3118 ultrasonic
Table 3 Suzuki couplings of 6a a
Boronic acid Time/h Product Yield (%)
27a 1.3 28a 63
27b 1.3 28b 72
27c 2 28c 47
27d 1 28d 63
27e 1 28e 86
27f 2 28f 45
27g 1.3 28g 75
27h 1 28h 66
a 1.0 equiv. 6a, 2.0 equiv. boronic acid, 5% Pd(PPh3)4, 4.0 equiv. Et3N,
DMF, 90 C.
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bath operating at 50 Hz. Iodotriﬂate 5a was prepared by a
known method and gave spectral data in agreement with those
reported.29
Boronic acids were purchased from Aldrich or Lancaster
Synthesis; stannanes 21b–21h were generously provided by
GlaxoWellcome. Copper bromide was prepared according to
Vogel.37
4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl triﬂuoromethane-
sulfonate 6a
Diethyl bromodiﬂuoromethylphosphonate (28.4 mmol, 7.59 g)
in DMA (7 ml) was added dropwise under nitrogen to a stirred
solution of activated zinc dust (28.4 mmol, 1.85 g) in DMA (7
ml) at 50–60 C. After stirring the suspension at room temper-
ature for 3 hours, CuBr (28.4 mmol, 4.06 g) was added in one
portion and stirring was continued for a further thirty minutes.
A solution of 5a (14.2 mmol, 5.0 g) in DMA (7 ml) was added
dropwise and the reaction was sonicated for three hours, before
being stirred at room temperature for a further 24 hours. The
mixture was diluted with diethyl ether (50 ml) and water (30
ml), ﬁltered through Celite and extracted with diethyl ether
(3 × 30 ml). The combined organic extracts were washed with a
saturated solution of NaHCO3 (5 × 20 ml) and brine (30 ml),
dried (MgSO4) and concentrated in vacuo to leave a pale yellow
oil (7.50 g) which was puriﬁed by column chromatography (30%
ethyl acetate in light petroleum) to aﬀord 6a (3.91 g, 66%) as a
colourless oil; Rf (30% ethyl acetate in light petroleum) 0.53
(Found: C, 34.99; H, 3.47. C12H14F5O6PS requires: C, 34.96; H,
3.42%); νmax(ﬁlm)/cm
1 2989m, 1604w, 1504m, 1428s, 1274s
(PO), 1252s, 1217br vs, 1142vs, 1020br vs, 889s, 844m, 757m;
δH (300 MHz, CDCl3) 7.70 (2 H, d, J 8, H-2, H-6), 7.36 (2 H,
d, J 8, H-3, H-5), 4.28–4.09 (4 H, m, -OCH2), 1.31 (6 H, t, J 7.4,
-CH2CH3); δC (75 MHz, CDCl3) 151.0, 133.1 (dt, 
2JC-F 22.3,
2JC-P 13.6), 128.6, 121.5, 118.9 (q, 
1JC-F 320.4), 117.5 (dt, 
1JC-F
263.9, 1JC-P 218.1), 65.0, 16.2; δF (282 MHz, CDCl3) 72.9 (3 F,
s), 108.9 (2 F, d, 2JF-P 112.5); δP (121 MHz, CDCl3) 5.83 (t,
2JF-P 112.5) [HRMS (CI, M[NH4]) Found: 430.051264. Calc.
for C12H18F5NO6PS: 430.052407]; m/z (CI) 430 (100%,
M[NH4]), 413 (15, M  1), 282 (75), 265 (55).
4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl nonaﬂuoro-
butanesulfonate 6b
Activated zinc dust (1.30 g, 19.9 mmol) in DMA (5 ml),
diethyl bromodiﬂuoromethylphosphonate (5.32 g, 19.9 mmol)
in DMA (5 ml), copper bromide (2.86 g, 19.9 mmol) and nona-
ﬂate 5b (5.00 g, 10.0 mmol) in DMA (3 ml) were treated and
worked up as described above. Concentration in vacuo aﬀorded
a yellow oil which was puriﬁed by column chromatography
(light petroleum) to aﬀord 6b (4.21 g, 75%) as a colourless oil
(purity by GC 97%); Rf (light petroleum) 0.42 (Found: C, 32.01;
H, 2.51. C15H14F11O6PS requires: C, 32.04; H, 2.51%); νmax(ﬁlm)/
cm1 2989w, 1503m, 1430s, 1354m, 1242br vs (PO), 1205vs,
1147vs, 1020br vs, 894s, 844m, 736m; δH (300 MHz, CDCl3)
7.72 (2 H, d, J 8.6, H-2, H-6), 7.37 (2 H, d, J 8.6, H-3, H-5),
4.30–4.10 (4 H, m, -OCH2), 1.30 (6 H, t, J 7.0, -CH2CH3); δC (75
MHz, CDCl3) 151.1, 133.0 (td, 
2JC-F 22.6, 
2JC-P 14.1), 128.4 (td,
3JC-F 6.8, 
3JC-P 2.3), 121.3, 119.2–118.1 (m), 117.2 (td, 
1JC-F
263.5, 1JC-P 217.6), 115.7–112.8 (m), 112.2–108.0 (m), 106.5–
105.6 (m), 65.0 (d, 2JC-P 7.4), 15.7 (d, 
3JC-P 5.7); δF (282 MHz,
CDCl3) 72.8 (3 F, t, 
3JF-F 9.5), 108.7 (2 F, t, 
2JF-F 12.7),
108.8 (2 F, d, 2JF-P 112.0), 120.86 to 120.9 (2 F, m),
125.8 to 125.9 (2 F, m); δP (121 MHz, CDCl3) 5.87 (t, 
2JP-F
112.0) [HRMS (ES, M[Na]) Found: 584.9987. Calc. for
C15H14O6F11NaPS: 584.9971]; m/z (CI) 580 (61%, M[NH4]) 563
(100, M  1), 425 (7), 279 (7), 109 (7).
4-[(Diisopropoxyphosphoryl)diﬂuoromethyl]phenyl triﬂuoro-
methanesulfonate 6c
Activated zinc dust (1.30 g, 20 mmol) in DMF (10 ml), diiso-
propyl bromodiﬂuoromethylphosphonate (5.90 g, 20 mmol) in
DMF (10 ml), copper bromide (2.86 g, 20 mmol) and triﬂate 5a
(3.52 g, 10.0 mmol) in DMF (2 ml) were treated and worked up
as described above. Concentration in vacuo aﬀorded a pale
yellow oil which was puriﬁed by column chromatography (30%
diethyl ether in light petroleum) to aﬀord 6c (1.36 g, 31%) as a
colourless oil (purity by GC 96%); Rf (30% ether in light petrol-
eum) 0.17; νmax(ﬁlm)/cm
1 2986m, 1604w, 1502m, 1428s, 1252m
(PO), 1215s, 1143s, 999s, 887m; δH (300 MHz, CDCl3) 7.71
(2 H, d, J 8.5, Ar-H), 7.34 (2 H, d, J 8.5, Ar-H), 4.83–4.69 (2 H,
m, -CH(CH3)2), 1.33 (6 H, d, J 6.2, -CH(CH3)2), 1.23 (6 H, d,
J 6.2, -CH(CH3)2); δC (75 MHz, CDCl3) 150.9, 133.4 (dt, 
2JC-F
22.6, 2JC-P 14.1), 128.8, 121.4, 118.7 (q, 
1JC-F 320.5), 117.1 (dt,
1JC-F 263.9, 
1JC-P 219.3), 74.3, 74.2, 24.1, 24.0, 23.5, 23.4; δF (282
MHz, CDCl3) 72.9 (3 F, s), 109.4 (2 F, d, 
2JF-P 112.5); δP (121
MHz, CDCl3) 4.07 (t, 
2JF-P 112.5) [HRMS (ES, M[Na])
Found: 463.0376. Calc. for C14H18F5NaO6PS: 463.0380]; m/z
(ES) 463 (90%, M[Na]), 421 (82), 379 (100).
3-[(Diethoxyphosphoryl)diﬂuoromethyl]-1-methoxybenzene 8
From diethyl bromodiﬂuoromethylphosphonate (6.41 mmol,
1.71 g) in DMA (2 ml), activated zinc dust (6.41 mmol, 0.42 g)
in DMA (2 ml), CuBr (6.41 mmol, 0.92 g), 3-iodoanisole (4.27
mmol, 1.00 g) in DMA (2 ml) which were reacted and worked
up as described above. Concentration in vacuo aﬀorded a yellow
oil (2.30 g) which was puriﬁed by column chromatography (20%
ethyl acetate in light petroleum) to aﬀord 8 (0.40 g, 32%) as a
colourless oil; Rf (20% ethyl acetate in light petroleum) 0.2
(Found: C, 49.11; H, 5.76. C12H17F2O4P requires: C, 48.99; H,
5.82%); νmax(ﬁlm)/cm
1 2985s, 1604s, 1588s, 1488s, 1454s, 1438s,
1275vs (PO), 1211s, 1043br vs, 794s, 749m, 698s, 682m; δH (300
MHz, CDCl3) 7.32 (1 H, dd, J 8.1, 7.7, H-5), 7.16 (1 H, d, J 7.7,
H-4), 7.09 (1 H, s, H-2), 6.97 (1 H, d, J 8.1, H-6), 4.25–4.03
(4 H, m, -OCH2), 3.78 (3 H, s, -OCH3), 1.27 (6 H, t, J 7.0,
-CH2CH3); δC (75 MHz, CDCl3) 159.7, 134.2 (dt, 
2JC-F 22.0,
2JC-P 14.1), 129.8, 118.7 (dt, J 7.3, 
3JC-P 2.8), 118.5, 118.2 (dt,
1JC-F 263.4, 
1JC-P 218.1), 111.8 (dt, 
3JC-F 7.4, 
3JC-P 2.3), 65.0 (d,
2JC-P 6.4), 55.5, 16.5 (d, 
3JC-P 5.0); δF (282 MHz, CDCl3) 108.2
(2 F, d, 2JF-P 116.9); δP (121 MHz, CDCl3) 5.31 (t, 
2JF-P 116.9)
[HRMS (CI, M  1) Found: 295.090726. Calc. for
C12H18F2O4P: 295.091079]; m/z (CI) 312 (72%, M[NH4]), 295
(100, M  1), 157 (20).
4-[(Diethoxyphosphoryl)diﬂuoromethyl]-1-methoxybenzene 9
Aryl diﬂuorophosphonate 9 was prepared under identical con-
ditions to 8 from 4-iodoanisole (4.27 mmol, 1.00 g) and diethyl
bromodiﬂuoromethylphosphonate (6.41 mmol, 1.71 g) to leave
a yellow oil (2.30 g) which was puriﬁed by column chrom-
atography (20% ethyl acetate in light petroleum) to aﬀord 9
(0.21 g, 17%) as a colourless oil; Rf (20% ethyl acetate in light
petroleum) 0.21 (Found: C, 48.99; H, 5.75. C12H17F2O4P
requires: C, 48.99; H, 5.82%); νmax(ﬁlm)/cm
1 2985m, 1614s,
1516s, 1254s (PO), 1019br s, 835m; δH (300 MHz, CDCl3)
7.51 (2 H, d, J 8.5, H-3, H-5), 6.91 (2 H, d, J 8.5, H-2, H-6),
4.24–4.01 (4 H, m, -OCH2), 3.78 (3 H, s, -OCH3), 1.26 (6 H, t,
J 7.0, -CH2CH3); δC (75 MHz, CDCl3) 161.4, 127.8, 124.5
(dt, 2JC-F 22.6, 
2JC-P 14.1), 118.2 (dt, 
1JC-F 262.8, 
1JC-P 221.0),
113.8, 64.7 (d, 2JC-P 6.4), 55.3, 16.4 (d, 
3JC-P 5.0); δF (282 MHz,
CDCl3) 107.1 (d, 
2JF-P 119.5); δP (121 MHz, CDCl3) 6.95
(t, 2JP-F 119.5) [HRMS (CI, M  1) Found: 295.091284. Calc.
for C12H18F2O4P: 295.091079]; m/z (CI) 295 (39%, M  1), 275
(10), 221 (7), 157 (100).
Benzyl (2-hydroxy-5-iodo)benzoate 11
Benzyl bromide (4.5 ml, 37.9 mmol) and potassium ﬂuoride
(4.84 g, 83.3 mmol) were dissolved in DMF (50 ml) with stirring
at room temperature. After 5 minutes, 5-iodosalicylic acid 10
(10.00 g, 37.9 mmol) was added in one portion and the mixture
was heated to 100 C and stirred at that temperature for 2 hours
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under an atmosphere of nitrogen. The mixture was cooled to
room temperature, quenched with water (50 ml) and extracted
with diethyl ether (3 × 75 ml). The combined organic extracts
were washed with water (3 × 100 ml) and brine (100 ml), dried
(MgSO4) and concentrated in vacuo to aﬀord a light pink solid
(13.62 g) which was recrystallised from light petroleum to
aﬀord 11 as a white solid (11.04 g, 82%); mp 50–53 C (light
petroleum); Rf (40% diethyl ether in light petroleum) 0.77
(Found: C, 47.38; H, 2.98. C14H11IO3 requires: C, 47.48; H,
3.13%); νmax(KBr)/cm
1 3462m, 1675s, 1602m, 1470m, 1286s,
1201s, 1091m, 694m; δH (300 MHz, CDCl3) 8.14 (1 H, d, J 2.2,
H-6), 7.74 (1 H, dd, J 8.8, J 2.2, H-4), 7.46–7.36 (5 H, m, Ph-H),
6.77 (1 H, d, J 8.8, H-3), 5.38 (2 H, s, -OCH2Ph); δC (75 MHz,
CDCl3) 168.8, 161.4, 144.2, 138.2, 134.9, 128.8, 128.5, 120.0,
114.6, 80.1, 67.5; m/z (EI) 354 (20%, [M]), 91 (100). The phen-
olic O–H was not observed in the 1H NMR spectrum.
Benzyl (5-iodo-2-triﬂuoromethylsulfonyloxy)benzoate 12
Triﬂuoromethanesulfonic anhydride (5.3 ml, 31.5 mmol) was
added dropwise to a cooled (ice–water bath) solution of benzyl
(2-hydroxy-5-iodo)benzoate 11 (10.14 g, 28.6 mmol) in pyridine
(20 ml). The reaction mixture was stirred for 18 hours at 0 C.
The resulting yellow mixture was diluted with water (50 ml) and
extracted with diethyl ether (3 × 50 ml). The combined organic
extracts were washed with water (3 × 100 ml) and brine (100
ml), dried (MgSO4) and concentrated in vacuo to recover a yel-
low oil which was puriﬁed by column chromatography (15%
diethyl ether in light petroleum) to aﬀord 12 (11.01 g, 79%) as a
pale yellow liquid (purity by GC 99%); Rf (15% diethyl ether in
light petroleum) 0.39 (Found: C, 37.19; H, 1.98. C15H10O5F3SI
requires: C, 37.06; H, 2.07%); νmax(ﬁlm)/cm
1 3034w, 1731vs
(CO), 1594m, 1474s, 1428vs, 1286vs, 1250vs (PO), 1213vs,
1170vs, 1140vs, 1072s, 889s, 832s, 749s, 609s; δH (300 MHz,
CDCl3) 8.36 (1 H, d, J 2.2, H-6), 7.91 (1 H, dd, J 8.8, 2.2, H-4),
7.47–7.36 (5 H, m, PhH), 7.03 (1 H, d, J 8.8, H-3), 5.40 (2 H, s,
-OCH2Ph); δC (75 MHz, CDCl3) 162.2, 148.2, 143.2, 141.4,
134.9, 129.0, 128.7, 126.1, 124.6, 118.7 (q, 1JC-F 320.8), 92.9,
68.1; δF (282 MHz, CDCl3) 73.1 (s) [HRMS (FAB, M  Na)
Found: 508.9159. Calc. for C15H10O5F3SINa: 508.9144]; m/z
(EI) 486 (44%, [M]), 379 (80), 359 (66) 247 (53), 91 (100).
Benzyl 5-[(diethoxyphosphoryl)diﬂuoromethyl]-2-(triﬂuoro-
methylsulfonyloxy)benzoate 13
From diethyl bromodiﬂuoromethylphosphonate (0.55 g, 2.1
mmol) in DMA (2 ml), activated zinc dust (0.13 g, 2.1 mmol) in
dry DMA (2 ml), freshly prepared copper() bromide (0.30 g,
2.1 mmol), 12 (0.50 g, 1.0 mmol) in DMA (2 ml), reacted and
worked up as described above. Concentration in vacuo aﬀorded
a yellow oil (0.81 g) which was puriﬁed by column chrom-
atography (60% diethyl ether in light petroleum) to aﬀord 13
(0.37 g, 67%) as a pale yellow oil (purity by GC 100%);
νmax(ﬁlm)/cm
1 2986m, 1735 (CO), 1431vs, 1276vs (PO),
1224vs, 1140vs, 1070vs, 1022vs, 893s, 752s, 699m; δH (300 MHz,
CDCl3) 8.29 (1 H, s, H-6), 7.87 (1 H, d, J 8.8, H-3), 7.47–7.34
(6 H, m), 5.42 (2 H, s, -OCH2Ph), 4.28–4.15 (4 H, m, -OCH2),
1.29 (6 H, t, J 7.2, -CH2CH3); δC (75 MHz, CDCl3) 162.8,
149.8, 134.9, 133.4 (td, 2JC-F 23.2, 
2JC-P 14.1), 132.4 (td, 
3JC-F 6.8,
3JC-P 2.3), 130.8 (td, 
3JC-F 6.8, 
3JC-P 2.3), 128.9, 128.7, 124.9,
123.3, 118.7 (q, 1JC-F 320.4), 116.9 (td, 
1JC-F 264.3, 
1JC-P 218.0),
68.0, 65.2 (d, 2JC-P 6.8), 16.3 (d, 
3JC-P 5.7); δF (121 MHz,
CDCl3) 73.1 (3 F, s), 109.1 (2 F, d, 
2JF-P 111.6); δP (121 MHz,
CDCl3) 5.38 (t, 
2JP-F 111.6) [HRMS (FAB, M  Na) Found:
569.0429. Calc. for C19H20F5O8PNa: 569.0434]; m/z (EI) 546
(16%, [M]), 439 (35), 412 (85), 307 (64), 91 (100).
4-Benzyloxy-3-iodo-5-methoxybenzaldehyde 14
A solution of 5-iodovanillin (5.65 mmol, 1.57 g) in DMF (2 ml)
was added dropwise under an atmosphere of nitrogen to a
stirred suspension of potassium carbonate (5.65 mmol, 0.78 g)
in DMF (2 ml) at 0 C. The suspension was stirred at 0 C for
50 minutes. Benzyl bromide (5.65 mmol, 0.67 ml) was added
dropwise and after stirring at 0 C for a further 30 minutes, the
reaction was allowed to warm to room temperature and stirred
for four hours. Water (10 ml) was added and the mixture was
extracted with diethyl ether (3 × 15 ml). The combined organic
extracts were washed with brine (10 ml), dried (MgSO4) and
concentrated in vacuo to leave a yellow oil (2.46 g) which was
puriﬁed by column chromatography (20% diethyl ether in light
petroleum) to aﬀord 14 (1.85 g, 89%) as an oﬀ white solid;
mp 54–56 C; Rf (20% diethyl ether in light petroleum) 0.24;
νmax(KBr)/cm
1 2984m, 1694s (CO), 1583s, 1560s, 1464s, 1275s
(PO), 1143s, 1042s, 954s, 738m, 692s, 671m; δH (300 MHz,
CDCl3) 9.82 (1 H, s, CHO), 7.84 (1 H, d, J 1.8, Ar-H), 7.58–
7.51 (2 H, m, Ar-H), 7.44–7.30 (4 H, m, Ar-H), 5.14 (2 H, s,
-OCH2Ph), 3.93 (3 H, s, -OCH3); δC (75 MHz, CDCl3) 189.8,
153.1, 152.9, 136.5, 134.9, 134.0, 128.7, 128.5, 111.0, 92.8, 74.8,
56.2. This material was used directly without further puriﬁ-
cation or characterisation.
4-Benzyloxy-3-[(diethoxyphosphoryl)diﬂuoromethyl]-5-
methoxybenzaldehyde 16
From diethyl bromodiﬂuoromethylphosphonate (3.05 mmol,
0.82 g) in DMA (2 ml), activated zinc dust (3.05 mmol, 0.20 g)
in DMA (2 ml), freshly prepared CuBr (3.05 mmol, 0.44 g), 14
(2.04 mmol, 0.75 g) in DMA (2 ml), reacted for 40 hours and
worked up as described above. Concentration in vacuo aﬀorded
a yellow oil (1.76 g) which was puriﬁed by column chrom-
atography (40% ethyl acetate in light petroleum) to aﬀord 16
(0.22 g, 25%) as a colourless oil; Rf (40% ethyl acetate in light
petroleum) 0.33; νmax(ﬁlm)/cm
1 2984m, 1698s (CO), 1586m,
1291br s (PO), 1020br s; δH (300 MHz, CDCl3) 9.91 (1 H, s,
CHO), 7.65 (1 H, s, H-2), 7.58 (1 H, s, H-6), 7.52 (2 H, d, J 6.6,
Ar-H), 7.41–7.29 (3 H, m, Ar-H), 5.15 (2 H, s, -OCH2Ph), 4.30–
4.04 (4 H, m, -OCH2CH3), 3.96 (3 H, s, -OCH3), 1.20 (6 H, t,
J 7.7, -CH2CH3); δC (75 MHz, CDCl3) 190.6, 154.3, 151.9,
136.9, 132.2, 128.5, 128.3, 128.2, 127.9–127.4 (m), 124.6 (t, 3JC-F
8.2), 118.0 (dt, 1JC-F 264.5, 
1JC-P 218.7), 112.2, 75.8, 65.0 (d, 
2JC-P
6.2), 56.2, 16.3 (d, 3JC-P 5.7); δF (282 MHz, CDCl3) 105.1 (d,
2JF-P 113.2); δP (121 MHz, CDCl3) 5.93 (t, 
2JP-F 113.2) [HRMS
(CI, M[H]) Found: 429.126534. Calc. for C20H24F2O6P:
429.127859]; m/z (CI) 429 (24%, M), 401 (13), 339 (9), 262 (8),
245 (100).
2-Benzyloxy-3,5-diiodobenzaldehyde 15
Benzyl ether 15 was prepared under identical conditions to 14
from 3,5-diiodosalicylaldehyde (8.02 mmol, 3.00 g) and benzyl
bromide (8.02 mmol, 0.95 ml) to aﬀord a yellow solid which
was recrystallised from diethyl ether–light petroleum to aﬀord
15 (3.71 g, 100%) as an oﬀ white solid; mp 98–101 C; δH (300
MHz, CDCl3) 9.91 (1 H, s, CHO), 8.37 (1 H, d, J 2.1, H-6), 8.06
(1 H, d, J 2.1, H-4), 7.47–7.36 (5 H, m, Ar-H), 5.05 (2 H, s);
δC (75 MHz, CDCl3) 187.7, 160.7, 152.7, 137.7, 134.7, 132.0,
129.2, 129.0, 128.9, 94.9, 89.6, 78.6. The material was used
directly without further puriﬁcation or characterisation.
2-Benzyloxy-3-[(diethoxyphosphoryl)diﬂuoromethyl]-5-iodo-
benzaldehyde 17a and 2-benzyloxy-5-[(diethoxyphosphoryl)-
diﬂuoromethyl]-3-iodobenzaldehyde 17b
From diethyl bromodiﬂuoromethylphosphonate (4.85 mmol,
1.30 g) in DMA (2 ml), activated zinc dust (4.85 mmol, 0.32 g)
in DMA (2 ml), freshly prepared CuBr (4.85 mmol, 0.69 g), and
16 (3.23 mmol, 1.50 g) in DMA (2 ml) which were reacted and
worked up as described above. Concentration in vacuo aﬀorded
a yellow oil (2.87 g) which was puriﬁed by column chromato-
graphy (30% ethyl acetate in light petroleum) to aﬀord the
aryl phosphonates 17a (0.32 g, 19%) and 17b (0.35 g, 21%) as
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colourless oils; for 17a Rf (30% ethyl acetate in light petroleum)
0.30; νmax(ﬁlm)/cm
1 2984s, 1693vs (CO), 1571s, 1445s, 1372s,
1272vs (PO), 1234vs, 1021br vs, 736s, 699s, 660m; δH (300
MHz, CDCl3) 10.05 (1 H, s, CHO), 8.29 (1 H, s, H-6), 8.01 (1 H,
s, H-4), 7.49–7.35 (5 H, m, CH2Ph), 5.10 (2 H, s, OCH2Ph), 4.34–
4.16 (4 H, m, -OCH2), 1.34 (6 H, t, 
3JH-H 7.0 Hz, -CH2CH3);
δC (75 MHz, CDCl3) 188.1, 162.6, 143.1 (t, 
3JC-F 5.6), 134.7,
131.2 (dt, 2JC-F 23.2, 
2JC-P 14.1), 130.4, 129.2, 129.0, 128.9, 127.2
(t, 3JC-F 5.1), 116.6 (dt, 
1JC-F 265.6, 
1JC-P 218.7), 93.6, 78.5, 64.5
(d, 2JC-P 6.8), 16.4 (d, 
3JC-P 5.7); δF (282 MHz, CDCl3) 108.7
(d, 2JF-P 113.5); δP (121 MHz, CDCl3) 5.57 (t, 
2JP-F 113.5)
[HRMS (FAB) Found: 546.993790. Calc. for C19H20F2INaO5P:
546.995891]; m/z (EI) 524 (19%, M), 496 (9), 433 (26), 397 (9),
91 (100); for 17b Rf (30% ethyl acetate in light petroleum) 0.40;
δH (300 MHz, CDCl3) 10.06 (1 H, s, CHO), 8.22 (1 H, s, H-6),
8.07 (1 H, s, H-4), 7.45–7.32 (5 H, m, CH2Ph), 5.04 (2 H, s,
-OCH2Ph), 4.24–4.06 (4 H, m, -OCH2), 1.20 (6 H, t, 
3JH-H 7.0,
-CH2CH3); δC (75 MHz, CDCl3) 187.0, 159.6, 142.8 (t, 
3JC-F
8.2), 140.5, 135.0, 132.5, 129.6 (dt, 2JC-F 22.0, 
2JC-P 13.0), 128.8,
128.6, 128.5, 117.1 (dt, 1JC-F 266.5, 
1JC-P 218.7), 88.0, 81.7, 65.1
(d, 2JC-P 6.8), 16.2 (d, 
3JC-P 5.7); δF (282 MHz, CDCl3) 105.7
(d, 2JF-P 111.6); δP (121 MHz, CDCl3) 5.44 (t, 
2JP-F 111.6)
[HRMS (FAB) Found: 546.994831. Calc. for C19H20F2INaO5P:
546.995891]; m/z (FAB) 547 (100%, M[Na]), 392 (6).
2-[(Diethoxyphosphoryl)diﬂuoromethyl]thiophene 19
From diethyl bromodiﬂuoromethylphosphonate (7.14 mmol,
1.91 g) in DMA (3 ml), activated zinc dust (7.14 mmol, 0.46 g)
in DMA (3 ml), freshly prepared CuBr (7.14 mmol, 1.05 g) and
2-iodothiophene (4.76 mmol, 0.53 ml) in DMA (3 ml) which
were reacted and worked up as described above. Concentration
in vacuo aﬀorded a yellow oil (1.95 g) which was puriﬁed by
column chromatography (40% diethyl ether in light petroleum)
to aﬀord 19 (0.79 g, 62%) as a colourless oil; Rf (40% diethyl
ether in light petroleum) 0.48 (Found: C, 40.09; H, 5.00.
C9H13F2O3PS requires: C, 40.00; H, 4.85%); νmax(ﬁlm)/cm
1
2987m, 1431m, 1272s (PO), 1242s, 1036br vs, 717m; δH (300
MHz, CDCl3) 7.53–7.39 (2 H, m, H-2, H-4), 7.10–7.04 (1 H, m,
H-3), 4.30–4.12 (4 H, m, -OCH2), 1.31 (6 H, t, 
3JH-H 7.0 Hz,
CH2CH3); δC (75 MHz, CDCl3) 133.7 (dt, 
2JC-F 26.0, 
2JC-P 17.0),
128.9, 128.8, 127.2, 97.9 (dt, 1JC-F 261.1, 
1JC-P 225.5), 65.0 (d,
2JC-P 6.4), 16.2 (d, 
3JC-P 4.8); δF (282 MHz, CDCl3) 96.9 (2 F, d,
2JF-P 114.4); δP (121 MHz, CDCl3) 5.41 (t, 
2JF-P 114.4) [HRMS
(CI) Found: 271.038054. Calc. for C9H14F2O3PS: 271.036936];
m/z (CI) 288 (10%, M[NH4]), 271 (82, M  1), 270 (9), 251
(14), 155 (25), 133 (100).
General procedure for Stille couplings from iodide 2 or triﬂate 6a:
1-{4-[(diethoxyphosphoryl)diﬂuoromethyl]phenyl}ethene 22a
PdCl2(PPh3)2 (0.4 mmol, 0.27 g) was added to a stirred solution
of iodide 2 (7.69 mmol, 3.0 g) and tributylstannylethene 21a
(8.07 mmol, 2.56 g) in DMF (15 ml) and the mixture was heated
to 60 C for one hour. After cooling, the black suspension was
diluted with water (15 ml) and ether (25 ml), and ﬁltered
through a pad of Harbolite. The mixture was extracted with
ether (3 × 20 ml), and the combined organic extracts were
washed with brine (20 ml). After drying (MgSO4), the solvent
was removed in vacuo to leave a brown oil (3.24 g) which was
puriﬁed by ﬂash chromatography (30% ethyl acetate in light
petroleum) to aﬀord alkene 22a (1.87 g, 84%) as a colourless oil;
RF (40% ethyl acetate in light petroleum) 0.57 (Found: C, 53.72;
H, 6.03. Calc. for C13H17F2O3P: C, 53.80; H, 5.90%); νmax(ﬁlm)/
cm1 2985m, 1261s (PO), 1017s, 843m; δH (300 MHz, CDCl3)
7.56 (2 H, d, J 8.1, H-2, H-6), 7.47 (2 H, d, J 8.1, H-3, H-5),
6.72 (1 H, dd, J 17.3, 11.0, H-1), 5.81 (1 H, d, Jtrans 17.3, H-2),
5.33 (1 H, d, Jcis 11.0, H-2), 4.28–4.06 (4 H, m, -OCH2), 1.30
(6 H, t, 3JH-H 7.0, CH2CH3); δC (75 MHz, CDCl3) 140.7, 135.9,
131.7 (dt, 2JC-F 22.0, 
2JC-P 13.6), 126.5 (dt, 
3JC-F 5.9, 
3JC-P 1.7),
126.2, 118.1 (dt, 1JC-F 263.4, 
1JC-P 218.7), 115.9, 64.8 (d, 
2JC-P
6.8), 16.4 (d, 3JC-P 5.7); δF (282 MHz, CDCl3) 108.3 (d, 
2JF-P
117.0); δP (121 MHz, CDCl3) 6.70 (t, 
2JP-F 117.0); m/z (CI) 308
(100%, M[NH4]), 291 (21, M  1).
1-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-1-ethoxy-
ethene 22b and 1-{4-[(diethoxyphosphoryl)diﬂuoromethyl]-
phenyl}ethanone 23. As above from 6a (1 mmol, 0.41 g)
and 1-(tributylstannyl)-1-ethoxyethene 21b (1 mmol, 0.36 g).
Following the usual work up, the residue (crude 22b) was redis-
solved in THF (6 ml). Dilute HCl (3 ml of 1 M solution) was
added and the mixture was stirred at room temperature for
3 hours. After extraction with ether (3 × 10 ml), the combined
organic extracts were washed with NaHCO3 (2 × 7 ml) and
brine (5 ml), dried (MgSO4) and concentrated in vacuo to leave
a yellow oil (0.23 g) which was puriﬁed by ﬂash column chrom-
atography (30% ethyl acetate in light petroleum) to aﬀord the
aryl ketone 23 (0.16 g, 52%) as a colourless oil; Rf (40% ethyl
acetate in light petroleum) 0.39 (Found: C, 51.26; H, 5.50.
C13H17F2O4P requires: C, 50.99; H, 5.59%); δH (300 MHz,
CDCl3) 7.98 (2 H, d, J 8.1, H-2, H-6), 7.67 (2 H, d, J 8.1, H-3,
H-5), 4.27–4.0 (4 H, m, -OCH2), 2.59 (3 H, s, CH3CO), 1.27
(6 H, t, 3JH-H 7.0, CH2CH3); δC (75 MHz, CDCl3) 197.2, 138.6,
136.7 (dt, 2JC-F 22.0, 
2JC-P 13.6), 128.6, 126.5 (dt, 
3JC-F 5.7), 117.5
(dt, 1JC-F 263.9, 
1JC-P 217.0), 64.8 (d, 
2JC-P 6.8), 26.6, 16.4 (d,
3JC-P 5.1); δF (282 MHz, CDCl3) 109.4 (d, 
2JF-P 113.5); δP (121
MHz, CDCl3) 6.02 (t, 
2JP-F 113.5) [HRMS (CI, M[NH4])
Found: 324.117480. Calc. for C13H21F2NO4P: 324.117628]; m/z
(EI) 306 (25%, M), 291 (27), 264 (31), 169 (97), 155 (100), 141
(47), 126 (80), 109 (94).
4-(2-Pyridyl)-1-[(diethoxyphosphoryl)diﬂuoromethyl]benzene
22c. As above from 6a (1 mmol, 0.41 g) and 2-(tributyl-
stannyl)pyridine 21c (1 mmol, 0.37 g). Following the usual work
up, puriﬁcation by ﬂash chromatography (40% ethyl acetate in
light petroleum) aﬀorded 22c (0.18 g, 52%) as a colourless oil;
Rf (40% ethyl acetate in light petroleum) 0.25; νmax(ﬁlm)/cm
1
2959m, 1702w, 1587m, 1467s, 1436s, 1259vs (PO), 1019vs,
783s; δH (300 MHz, CDCl3) 8.69 (1 H, d, J 4.8, H-6), 8.07 (2 H,
d, J 8.1, H-2, H-6), 7.79–7.64 (4 H, m, H-3, H-5, H-4), 7.30–
7.23 (1 H, m, H-5), 4.30–4.10 (4 H, m, -OCH2), 1.31 (6 H, t, J 7.0,
-CH2CH3); δC (75 MHz, CDCl3) 150.1, 149.7, 141.5, 136.8,
132.8 (dt, 2JC-F 22.0, 
2JC-P 13.6), 126.8, 126.6 (t, 
3JC-F 5.1), 122.6,
120.7, 117.9 (dt, 1JC-F 262.8, 
1JC-P 218.1), 64.7 (d, 
2JC-P 6.8), 16.2
(d, 3JC-P 5.7); δF (282 MHz, CDCl3) 108.5 (d, 
2JF-P 117.0);
δP (121 MHz, CDCl3) 6.61 (t, 
2JP-F 117.0) [HRMS (ES, M[Na])
Found: 364.0883. Calc. for C16H18F2NNaO3P: 364.0890]; m/z
(LCMS, CI, 4.30 min) 342 (100%, M  1), 322 (3), 314 (23).
4-(2-Furyl)-1-[(diethoxyphosphoryl)diﬂuoromethyl]benzene
22d. As above from 6a (1 mmol, 0.41 g) and 2-(tributylstannyl)-
furan 21d (1 mmol, 0.36 g). Following the usual work up, puriﬁ-
cation by ﬂash chromatography (30% ethyl acetate in light
petroleum) aﬀorded the furyl benzene derivative 22d (0.26 g,
79%) as a colourless oil; Rf (40% ethyl acetate in light petrol-
eum) 0.50; νmax(ﬁlm)/cm
1 2987m, 1770m, 1731m, 1693m,
1409m, 1258s (PO), 1022br s, 839m, 794m, 750m; δH (300
MHz, CDCl3) 7.70 (2 H, d, J 8.1, H-2, H-6), 7.58 (2 H, d, J 8.1,
H-3, H-5), 7.44 (1 H, d, J 1.8, H-5), 6.69 (1 H, d, J 3.7, H-3),
6.44 (1 H, dd, J 3.7, 1.8, H-4), 4.26–4.11 (4 H, m, -OCH2), 1.26
(6 H, t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3) 152.8, 142.9,
133.0, 131.0 (dt, 2JC-F 22.0, 
2JC-P 13.6), 126.7 (dt, 
3JC-F 5.4, 
3JC-P
1.7), 123.6, 118.0 (dt, 1JC-F 263.4, 
1JC-P 219.3), 111.9, 106.6, 64.8
(d, 2JC-P 6.2), 16.3 (d, 
3JC-P 5.7); δF (282 MHz, CDCl3) 108.4
(d, 2JF-P 117.0); δP (121 MHz, CDCl3) 6.64 (t, 
2JP-F 117.0)
[HRMS (ES, M[Na]) Found: 353.0718. Calc. for C15H17F2-
NaO4P: 353.0730]; m/z (LCMS, CI, 4.62 min) 331 (28%,
M  1), 311 (100), 283 (12), 219 (27).
2-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-5-(1,3-
dioxolan-2-yl)furan 22e. As above from triﬂate 6a (1 mmol,
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0.41 g) and 2-(tributylstannyl)-5-(1,3-dioxolan-2-yl)furan 21e
(1 mmol, 0.43 g). Following the usual work up, puriﬁcation by
ﬂash chromatography (40% ethyl acetate in light petroleum)
aﬀorded 22e (0.24 g, 60%) as a yellow oil; Rf (40% ethyl acetate
in light petroleum) 0.21; δH (300 MHz, CDCl3) 7.71 (2 H, d,
J 8.1, H-3, H-5), 7.58 (2 H, d, J 8.1, H-2, H-6), 6.67 (1 H, d,
J 3.3, H-4), 6.67 (1 H, d, J 3.3, H-3), 5.95 (1 H, s, CHO2), 4.28–
3.90 (8 H, m, -OCH2CH3, -OCH2CH2), 1.29 (6 H, t, J 7.0,
-CH2CH3); δC (75 MHz, CDCl3) 153.3, 151.6, 133.3 (dt, 
2JC-F
22.6, 2JC-P 13.6), 132.7, 126.6 (t, 
3JC-F 4.5), 123.8, 117.9 (dt, 
1JC-F
262.8, 1JC-P 218.1), 110.8, 107.0, 97.7, 65.2, 65.0 (d, 
2JC-P 6.8),
16.3 (d, 3JC-P 5.7); δF (282 MHz, CDCl3) 108.6 (d, 
2JF-P 117.0);
δP (121 MHz, CDCl3) 6.59 (t, 
2JP-F 117.0); m/z (LCMS, CI, 4.48
min) 403 (100%, M  1), 383 (75), 291 (27), 243 (37). The acetal
was hydrolysed without further characterisation.
2-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-5-furan-
carbaldehyde 24. Aqueous HCl (2.0 ml of a 2 M solution) was
added to a stirred solution of acetal 22e (0.97 mmol, 0.39 g) in
THF (6 ml). After stirring at room temperature for twenty min-
utes the mixture was diluted with water (3 ml), and extracted
with ether (3 × 6 ml). The combined organic extracts were
washed with NaHCO3 (2 × 5 ml) and brine (5 ml), dried
(MgSO4) and concentrated in vacuo to leave a yellow oil (0.36 g)
which was puriﬁed by column chromatography (40% diethyl
ether in isohexane to 100% ether) to aﬀord aldehyde 24 (0.25 g,
77%) as a yellow solid; mp 67–69 C; Rf (40% ethyl acetate
in isohexane) 0.13 (Found: C, 53.54; H, 4.76. C16H17F2O5P
requires: C, 53.64; H, 4.78%); νmax(KBr)/cm
1 2958m, 1725m,
1678vs (CO), 1668s, 1485m, 1254vs (PO), 1024br vs, 807m,
773m; δH (300 MHz, CDCl3) 9.67 (1 H, s, CHO), 7.89 (2 H, d,
J 8.5, H-3, H-5), 7.65 (2 H, d, J 8.5, H-2, H-6), 7.33 (1 H, d,
J 3.7, H-4), 6.92 (1 H, d, J 3.7, H-3), 4.30–4.08 (4 H, m, -OCH2),
1.31 (6 H, t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3) 177.4, 157.8,
152.3, 133.4 (dt, 2JC-F 22.0, 
2JC-P 13.6), 131.1, 126.9 (t, 
3JC-F 5.9),
125.1, 123.3, 117.7 (dt, 1JC-F 263.6, 
1JC-P 218.1), 108.9, 64.9 (d,
2JC-P 6.8), 16.3 (d, 
3JC-P 5.1); δF (282 MHz, CDCl3) 109.0 (d,
2JF-P 114.4); δP (121 MHz, CDCl3) 6.30 (t, 
2JP-F 114.4) [HRMS
(CI, M  1) Found: 359.086402. Calc. for C16H18F2O5P:
359.085994]; m/z (LCMS, CI, 4.30 min) 376 (30%, M[NH4]),
359 (100, M  1), 339 (36).
2-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-1-
methylpyrrole-5-carbaldehyde 22f. As above from triﬂate 6a
(1 mmol, 0.41 g) and N-methyl-5-tributylstannylpyrrole-2-
carbaldehyde 21f (1 mmol, 0.40 g). Following the usual work
up, puriﬁcation by ﬂash chromatography (30% ethyl acetate in
light petroleum) aﬀorded aldehyde 22f as a brown solid which
recrystallised from ether–light petroleum as light brown prisms
(0.20 g, 53%); mp 71–73 C; Rf (40% ethyl acetate in light
petroleum) 0.23 (Found: C, 54.83; H, 5.25; N, 3.74. C17H20F2-
NO4P requires: C, 54.99; H, 5.43; N, 3.77%); νmax(KBr)/cm
1
3470m, 1661vs (CO), 1464m, 1279m (PO), 1116s, 1052s,
1026s, 788m, 568m; δH (300 MHz, CDCl3) 9.59 (1 H, s, CHO),
7.70 (2 H, d, J 8.1, H-3, H-5), 7.50 (2 H, d, J 8.1, H-2, H-6),
7.0 (1 H, d, J 4.0, H-4), 6.33 (1 H, d, J 4.0, H-3), 4.31–4.15 (4 H,
m, -OCH2), 1.33 (6 H, t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3)
179.8, 142.8, 133.6, 133.4, 132.7 (dt, 2JC-F 22.0, 
2JC-P 14.1),
129.2, 126.7 (t, 3JC-F 5.7), 124.4, 117.9 (dt, 
1JC-F 263.4, 
1JC-P
218.2), 111.2, 65.0 (d, 2JC-P 6.8), 34.5, 16.4 (d, 
3JC-P 5.1); δF (282
MHz, CDCl3) 108.6 (d, 
2JF-P 114.4); δP (121 MHz, CDCl3)
6.34 (t, 2JP-F 114.4) [HRMS (CI, M[H]) Found: 372.117437.
Calc. for C17H21F2NO4P: 372.117628]; m/z (LCMS, CI, 4.41)
372 (100%, M[NH4]), 359 (100, M  1), 352 (22), 260 (12),
232 (22).
4-(2-Thienyl)-1-[(diethoxyphosphoryl)diﬂuoromethyl]benzene
22g. As above from triﬂate 6a and 2-(tributylstannyl)thiophene
21g. Following the usual work up, puriﬁcation by ﬂash chrom-
atography (30% ethyl acetate in light petroleum) aﬀorded a
white solid which recrystallised from ether–light petroleum to
aﬀord 22g (0.22 g, 64%) as white needles; mp 59–60 C; Rf (40%
ethyl acetate in light petroleum) 0.57 (Found: C, 51.97; H, 5.15.
C15H17F2O3PS requires: C, 52.02; H, 4.95%); νmax(KBr)/cm
1
1609w, 1265s (PO), 1050s, 1014vs, 822m, 566m; δH (300 MHz,
CDCl3) 7.68 (2 H, d, J 8.5, H-3, H-5), 7.61 (2 H, d, 
3JHa-Hb 8.5
Hz, H-2, H-6), 7.37 (1 H, d, J 3.3, H-3), 7.32 (1 H, d, J 5.2,
H-5), 7.01 (1 H, dd, J 5.2, 3.3, H-4), 4.31–4.08 (4 H, m, -OCH2),
1.32 (6 H, t, 3JH-H 7.0, -CH2CH3); δC (75 MHz, CDCl3) 143.0,
136.8, 131.3 (dt, 2JC-F 22.1, 
2JC-P 14.1), 128.3, 126.9 (t, 
3JC-F 5.1),
125.9, 125.8, 124.2, 118.0 (dt, 1JC-F 262.8, 
1JC-P 219.3), 64.8 (d,
2JC-P 6.8), 16.4 (d, 
3JC-P 5.7); δF (282 MHz, CDCl3) 108.4 (d,
2JF-P 115.7); δP (121 MHz, CDCl3) 6.77 (t, 
2JP-F 115.7) [HRMS
(CI, M[NH4]) Found: 364.095758. Calc. for C15H21F2NO3PS:
364.094785]; m/z (CI) 347 (46%, M  1), 210 (100), 352 (22).
4-Thiazol-2-yl-1-[(diethoxyphosphoryl)diﬂuoromethyl]-
benzene 22h. As above from triﬂate 6a (1 mmol, 0.41 g) and
2-(tributylstannyl)thiazole 21h (1 mmol, 0.36 g). Following the
usual work up, puriﬁcation by ﬂash chromatography (30% ethyl
acetate in light petroleum) aﬀorded biaryl 22h (0.18 g, 52%) as a
colourless oil; Rf (40% ethyl acetate in light petroleum) 0.36
(Found: C, 48.50; H, 4.83; N, 3.97. C14H16F2NO3PS requires: C,
48.41; H, 4.64; N, 4.03%); νmax(ﬁlm)/cm
1 2956m, 1480w, 1262s,
1021s, 834m, 755m; δH (300 MHz, CDCl3) 8.02 (2 H, d, J 8.1,
H-3, H-5), 7.86 (1 H, d, J 3.3, H-5), 7.67 (2 H, d, J 8.1, H-2,
H-6), 7.36 (1 H, d, J 3.3, H-4), 4.28–4.05 (4 H, m, -OCH2), 1.29
(6 H, t, J 7.0, CH2CH3); δC (75 MHz, CDCl3) 167.8, 144.1,
135.7, 134.1 (dt, 2JC-F 22.1, 
2JC-P 13.6), 127.0 (t, 
3JC-F 5.1), 126.5,
119.8, 117.8 (dt, 1JC-F 263.9, 
1JC-P 218.1), 64.9 (d, 
2JC-P 6.8), 16.4
(d, 3JC-P 5.7); δF (282 MHz, CDCl3) 108.4 (d, 
2JF-P 115.7);
δP (121 MHz, CDCl3) 6.36 (t, 
2JP-F 115.7) [HRMS (CI, M  1)
Found: 348.063507. Calc. for C14H17F2NO3PS: 348.063485]; m/z
(LCMS, CI, 4.37 min) 348 (100%, M  1), 320 (6), 188 (11).
Benzyl 5-[(diethoxyphosphoryl)diﬂuoromethyl]-2-(2-furyl)-
benzoate 25
A solution of triﬂate 13 (0.546 g, 1 mmol), 2-(tributyl-
stannyl)furan 21d (0.357 g, 1 mmol), Pd2dba3CHCl3 (0.026 g,
2.5 mol%), copper() iodide (0.019 g, 0.1 mmol) and triphenyl-
phosphine (0.0525 g, 0.2 mmol) in dry degassed DMF (1 ml)
was heated at 80 C for 6 hours. The mixture was cooled, par-
titioned between water (10 ml) and ethyl ether (10 ml) and
ﬁltered through Celite. The aqueous phase was separated and
extracted with ethyl ether (3 × 10 ml) then the combined
organic extracts were dried and concentrated in vacuo to aﬀord
a yellow oil. Column chromatography (40% ethyl acetate in
light petroleum) aﬀorded 25 (0.324 g, 70%) as a yellow oil;
Rf (40% ethyl acetate in light petroleum) 0.12; νmax(ﬁlm)/cm
1
2981m, 1732vs (CO), 1614m, 1273vs (PO), 1225vs, 1020br vs,
739s, 698m; δH (300 MHz, CDCl3) 7.86 (1 H, s, H-6), 7.75–7.68
(2 H, m, H-5, H-4), 7.34–7.33 (6 H, m, H-3, CH2Ph), 6.61 (1 H,
d, J 3.3, H-3), 6.42 (1 H, dd, J 3.3, 1.7, H-4), 5.31 (2 H, s,
-OCH2Ph), 4.27–4.15 (4 H, m, -OCH2CH3), 1.33–1.28 (6 H, m,
-OCH2CH3); δC (75 MHz, CDCl3) 168.1, 151.2, 143.4, 135.3,
131.9, 131.8 (td, 2JC-F 22.6, 
2JC-P 14.1), 131.8, 128.7 (td, 
3JC-F 6.8,
3JC-P 2.3), 128.7, 128.6, 128.4, 127.9, 127.2 (td, 
3JC-F 7.4, 
3JC-P
2.8), 117.5 (td, 1JC-F 263.9, 
1JC-P 218.2), 111.8, 109.5, 67.5, 65.0
(d, 3JC-P 6.8), 16.3 (d, 
3JC-P 5.6); δF (282 MHz, CDCl3) 108.9
(d, 2JF-P 114.7); δP (121 MHz, CDCl3) 6.13 (t, 
2JP-F 114.7)
[HRMS (ES, M  1) Found: 487.1095. Calc. for C23H23F2-
NaO6P: 487.1098]; m/z (ES) 487 (100%, M[Na]).
1-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-2-(trimethyl-
silyl)ethyne 26
PdCl2(PPh3)2 (5 mol%, 0.02 g) was added under an atmosphere
of nitrogen to a stirred solution of triﬂate 6a (0.24 mmol, 0.1 g),
trimethylsilylethyne (0.34 g, 0.05 ml) and triethylamine (0.15
ml) in DMF (1 ml) and the mixture was heated to 90 C for one
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hour. After cooling, the black suspension was diluted with ethyl
acetate (10 ml) and ﬁltered through a pad of Harbolite. The
mixture was washed with brine (2 ml), dried (MgSO4), and
concentrated in vacuo to leave a yellow oil (0.12 g) which was
puriﬁed by column chromatography (20% ethyl acetate in iso-
hexane) to aﬀord alkyne 26 (0.07 g, 81%) as a pale yellow oil; Rf
(20% ethyl acetate in isohexane) 0.20; δH (300 MHz, CDCl3)
7.58–7.48 (4 H, m, Ar-H), 4.28–4.0 (4 H, m, -OCH2), 1.29 (6 H,
t, J 7.0, -CH2CH3), 0.25 (9 H, s, -SiCH3); δC (75 MHz, CDCl3)
132.5 (dt, 2JC-F 22.0, 
2JC-P 14.1), 132.0, 126.3 (t, 
3JC-F 5.6), 126.2,
117.9 (dt, 1JC-F 263.4, 
1JC-P 218.1), 104.0, 96.7, 65.0 (d, 
2JC-P 6.8),
16.3 (d, 3JC-P 5.1), 0.0; δF (282 MHz, CDCl3) 108.9 (d, 
2JF-P
115.7); δP (121 MHz, CDCl3) 6.44 (t, 
2JP-F 115.7) [HRMS
(CI, M  1) Found: 361.120399. Calc. for C16H24F2O3PSi:
361.120043]; m/z (LCMS, CI, 5.11 min) 361 (50%, M  1), 341
(72), 313 (20), 249 (46), 201 (100).
General procedure for Suzuki coupling reactions: 1-{4-
[(diethoxyphosphoryl)diﬂuoromethyl]phenyl}butane 28a
PdCl2(PPh3)2 (5 mol%) was added under an atmosphere of
nitrogen to a stirred solution of triﬂate 6a (1.0 mmol), boronic
acid 27a (2.0 mmol) and triethylamine (4.0 mmol, 0.56 ml) in
DMF (3 ml) and the mixture was heated to 90 C for the time
indicated (consumption of the triﬂate as shown by TLC). After
cooling, the black suspension was diluted with ethyl acetate,
and washed sequentially with aqueous solutions of NaHCO3
(3 ml), water (3 ml), 2 M citric acid (3 ml) and brine (3 ml).
After drying (MgSO4), the solvent was removed in vacuo. Puri-
ﬁcation by ﬂash chromatography (20% ethyl acetate in isohex-
ane) aﬀorded 28a (0.20 g, 63%) as a colourless oil; Rf (20% ethyl
acetate in isohexane) 0.19 (Found: C, 55.92; H, 7.29. C15H23-
F2O3P requires: C, 56.25; H, 7.24%); νmax(ﬁlm)/cm
1 2932w,
1271s (PO), 1048s, 1019s; δH (300 MHz, CDCl3) 7.49 (2 H, d,
J 7.7, H-3, H-5), 7.24 (2 H, d, J 7.7, H-2, H-6), 4.27–4.0 (4 H,
m, -OCH2), 2.62 (2 H, J 7.7, ArCH2-), 1.65–1.52 (2 H, m,
-CH2Et), 1.37–1.21 (8 H, m, -CH2CH2CH3, -OCH2CH3), 0.90
(3 H, t, J 7.2, -CH2CH2CH3); δC (75 MHz, CDCl3) 145.9, 129.8
(dt, 2JC-F 22.0, 
2JC-P 13.6), 128.5, 126.1 (dt, 
3JC-F 6.5, 
3JC-P 2.3),
118.3 (dt, 1JC-F 262.8, 
1JC-P 219.3), 64.7 (d, 
2JC-P 6.8), 35.5, 33.4,
22.3, 16.3 (d, 3JC-P 5.7), 13.9; δF (282 MHz, CDCl3) 107.8 (d,
2JF-P 118.3); δP (121 MHz, CDCl3) 6.95 (t, 
2JP-F 118.3) [HRMS
(CI, M  1) Found: 321.142830. Calc. for C15H24F2O3P:
321.143115]; m/z (LCMS, CI, 4.93 min) 321 (34%, M  1), 301
(33), 273 (8), 209 (21), 181 (25), 161 (100).
4-Chloro-1-{4-[(diethoxyphosphoryl)diﬂuoromethyl]phenyl}-
benzene 28b. Aryl triﬂate 6a and 4-chlorophenylboronic acid
were treated as described above for 80 minutes. Following the
usual work up, puriﬁcation by ﬂash chromatography (30% ethyl
acetate in isohexane) aﬀorded the biaryl chloride 28b (0.27 g,
72%) as a pale yellow oil; Rf (40% ethyl acetate in isohexane)
0.39 (Found: C, 54.67; H, 5.00. C17H18ClF2O3P requires: C,
54.49; H, 4.84%); νmax(ﬁlm)/cm
1 2985w, 1613w, 1487m, 1260s
(PO), 1018s, 817s; δH (300 MHz, CDCl3) 7.68 (2 H, d, J 8.5,
H-3, H-5), 7.62 (2 H, d, J 8.5, H-2, H-6), 7.52 (2 H, d, J 8.5,
H-3, H-5), 7.42 (2 H, d, J 8.5, H-2, H-6), 4.32–4.10 (4 H, m,
-OCH2), 1.33 (6 H, t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3)
142.7, 138.2, 134.2, 131.7 (dt, 2JC-F 22.0, 
2JC-P 13.6), 129.1,
128.5, 127.0, 126.9 (t, 3JC-F 6.2), 118.1 (dt, 
1JC-F 263.4, 
1JC-P
218.7), 64.9 (d, 2JC-P 6.8), 16.4 (d, 
3JC-P 5.7); δF (282 MHz,
CDCl3) 108.3 (d, 
2JF-P 115.7); δP (121 MHz, CDCl3) 6.62 (t,
2JP-F 115.7); [HRMS (CI, M  1) Found: 375.072243. Calc. for
C17H19ClF2O3P: 375.072842]; m/z (LCMS, CI, 4.98 min) 394
(9%, 37M[NH4]), 392 (29%, 35M[NH4]), 377 (29, 37M  1),
375 (100, 35M  1), 355 (34).
4-Bromo-1-{4-[(diethoxyphosphoryl)diﬂuoromethyl]phenyl}-
benzene 28c. Aryl triﬂate 6a and 4-bromophenylboronic acid
were treated as described above for 80 minutes. Following the
usual work up, puriﬁcation by ﬂash chromatography (40% ether
in isohexane) aﬀorded biaryl 28c (0.20 g, 48%) as a pale yellow
oil; Rf (40% ethyl acetate in isohexane) 0.20; νmax(ﬁlm)/cm
1
2933m, 1613m, 1588m, 1483s, 1390m, 1260s (PO), 1020br s,
813s; δH (300 MHz, CDCl3) 7.68 (2 H, d, J 8.1, H-3, H-5), 7.62
(2 H, d, J 8.1, H-4, H-6), 7.58 (2 H, d, J 8.5, H-3, H-5), 7.45
(2 H, d, J 8.5, H-4, H-6), 4.33–4.11 (4 H, m, -OCH2), 1.33 (6 H,
t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3) 142.4, 138.9, 132.1,
131.7 (dt, 2JC-F 22.0, 
2JC-P 13.6), 128.9, 127.0, 126.9 (t, 
3JC-F 6.2),
122.4, 118.5 (dt, 1JC-F 263.9, 
1JC-P 218.5), 64.9 (d, 
2JC-P 6.8), 16.4
(d, 3JC-P 5.1); δF (282 MHz, CDCl3) 108.4 (d, 
2JF-P 116.4);
δP (121 MHz, CDCl3) 6.60 (t, 
2JP-F 116.4) [HRMS (CI, M  1)
Found: 419.0223. Calc. for C17H19BrF2O3P: 419.0209]; m/z
(CI) 438 (100%, 81M[NH4]), 436 (100, 79M[NH4]), 421 (31,
81M  1), 420 (17, 81M), 419 (31, 79M  1), 418 (12, 79M),
358 (14).
2-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}benzalde-
hyde 28d. Aryl triﬂate 6a and 2-formylphenylboronic acid
were treated as described above for 1 hour. Following the
usual work up, puriﬁcation by ﬂash chromatography (20% ethyl
acetate in isohexane) aﬀorded biaryl 28d (0.23 g, 63%) as a
yellow oil; Rf (40% ethyl acetate in isohexane) 0.13 (Found:
C, 58.68; H, 4.99. C18H19F2O4P requires: C, 58.70; H, 5.20%);
δH (300 MHz, CDCl3) 9.91 (1 H, s, CHO), 7.98 (1 H, d, J 7.4,
H-3), 7.69 (2 H, d, J 7.7, H-3, H-5), 7.66–7.58 (1 H, m, H-5),
7.53–7.36 (4 H, m, H-4, H-6, H-2, H-6), 4.31–4.10 (4 H, m,
-OCH2), 1.30 (6 H, t, J 7.0, -CH2CH3); δC (75 MHz, CDCl3)
191.8, 144.6, 140.4, 133.7, 133.6, 132.5 (dt, 2JC-F 22.0, 
2JC-P
14.1), 130.7, 130.1, 128.4, 127.9, 126.4 (t, 3JC-F 5.1), 118.0 (dt,
1JC-F 263.4, 
1JC-P 218.7), 64.0 (d, 
2JC-P 6.8), 16.4 (d, 
3JC-P 5.1);
δF (282 MHz, CDCl3) 108.4 (d, 
2JF-P 115.7); δP (121 MHz,
CDCl3) 6.40 (t, 
2JP-F 115.7) [HRMS (CI, M  1) Found:
369.107004. Calc. for C18H20F2O4P: 369.106729]; m/z (LCMS,
CI, 4.55 min) 386 (8%, M[NH4]), 369 (100, M  1), 341 (19).
1-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-3-nitro-
benzene 28e. Aryl triﬂate 6a and 3-nitrophenylboronic acid
were treated as described above for 1 hour. Following the usual
work up, puriﬁcation by ﬂash chromatography (30% ethyl acet-
ate in isohexane) aﬀorded an oﬀ white solid which crystallised
from ether–isohexane to yield biaryl 28e (0.33 g, 86%) as white
needles, mp 65–67 C; Rf (40% ethyl acetate in isohexane) 0.23
(Found: C, 53.07; H, 4.51; N, 3.59. C17H18F2NO5P requires: C,
52.99; H, 4.71; N, 3.64%); δH (300 MHz, CDCl3) 8.42 (1 H, s,
H-2), 8.20 (1 H, d, J 8.1, H-4), 7.90 (1 H, d, J 7.7, H-6), 7.72 (2 H,
d, J 8.8, H-3, H-5), 7.68 (2 H, d, J 8.8, H-4, H-6), 7.61 (1 H,
dd, J 8.1, 7.7, H-5), 4.32–4.10 (4 H, m, -OCH2), 1.33 (6 H, t,
J 7.0, -CH2CH3); δC (75 MHz, CDCl3) 148.8, 141.7, 141.1,
133.2, 132.8 (dt, 2JC-F 22.0, 
2JC-P 14.1), 130.0, 127.3, 127.2,
122.7, 122.1, 118.0 (dt, 1JC-F 263.4, 
1JC-P 218.2), 64.9 (d, 
2JC-P
6.8), 16.2 (d, 3JC-P 5.1); δF (282 MHz, CDCl3) 108.5 (d, 
2JF-P
115.7); δP (121 MHz, CDCl3) 6.41 (t, 
2JP-F 115.7) [HRMS
(CI, M  1) Found: 386.096478. Calc. for C17H19F2NO5P:
386.096893]; m/z (LCMS, CI, 4.72 min) 403 (59%, M[NH4]),
386 (100, M  1), 366 (10), 274 (9).
1-{4-[(Diethoxyphosphoryl)diﬂuoromethyl]phenyl}-3,4-
dimethoxybenzene 28f. Aryl triﬂate 6a and 3,4-dimethoxy-
phenylboronic acid were treated as described above for 2
hours. Following the usual work up, puriﬁcation by ﬂash
chromatography (80% ether in isohexane) aﬀorded the biaryl
28f (0.18 g, 45%) as a pale yellow semi-solid; Rf (40% ethyl
acetate in isohexane) 0.29 (Found: C, 57.05; H, 5.75.
C19H23F2O5P requires: C, 57.00; H, 5.79%); νmax(KBr)/cm
1
1611m, 1526m, 1504m, 1266s (PO), 1029s, 805m, 576m;
δH (300 MHz, CDCl3) 7.66 (2 H, d, J 9.4, H-3, H-5), 7.62 (2 H,
d, J 9.4, H-4, H-6), 7.16 (1 H, dd, J 8.5, 1.2, H-6), 7.10 (1 H, d,
J 1.2, H-2), 6.95 (1 H, d, J 8.5, H-5), 4.29–4.10 (4 H, m, -OCH2),
3.94 (3 H, s, -OCH3), 3.92 (3 H, s, -OCH3), 1.33 (6 H, t, J 7.0 Hz,
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-CH2CH3); δC (75 MHz, CDCl3) 149.1, 149.0, 143.3, 132.7,
130.6 (dt, 2JC-F 22.0, 
2JC-P 13.6), 126.6, 126.5 (t, 
3JC-F 6.2), 119.4,
118.0 (dt, 1JC-F 263.4, 
1JC-P 219.3), 111.3, 110.1, 64.6 (d, 
2JC-P
6.8), 55.8, 16.2 (d, 3JC-P 5.7); δF (282 MHz, CDCl3) 108.2 (d,
2JF-P 116.9); δP (121 MHz, CDCl3) 6.77 (t, 
2JP-F 116.9) [HRMS
(CI, M  1) Found: 401.132944. Calc. for C19H24F2O5P:
401.132944]; m/z (LCMS, CI, 4.53 min) 418 (100%, M[NH4]),
401 (67, M  1), 381 (54).
4-(3-Thienyl)-1-[(diethoxyphosphoryl)diﬂuoromethyl]benzene
28g. Aryl triﬂate 6a and 3-thienyl boronic acid were treated
as described above for 80 minutes. Following the usual work up,
puriﬁcation by ﬂash chromatography (30% ethyl acetate in iso-
hexane) aﬀorded a light brown solid which crystallised from
ether–isohexane to yield biaryl 28g (0.26 g, 75%) as oﬀ-white
prisms, mp 60–62 C; Rf (40% ethyl acetate in isohexane) 0.39
(Found: C, 52.12; H, 4.79. C15H17F2O3PS requires: C, 52.02; H,
4.95%); νmax(KBr)/cm
1 1611w, 1265s (PO), 1014s, 786s, 567s;
δH (300 MHz, CDCl3) 7.67 (2 H, d, J 8.8, H-3, H-5), 7.63 (2 H, d,
J 8.8, H-2, H-6), 7.54–7.50 (1 H, m, H-4), 7.43–7.39 (2 H, m,
H-2, H-5), 4.30–4.09 (4 H, m, -OCH2), 1.32 (6 H, t, J 7.0,
-CH2CH3); δC (75 MHz, CDCl3) 141.2, 138.2, 131.1 (dt, 
2JC-F
22.0, 2JC-P 13.6), 126.8 (t, 
3JC-F 6.2), 126.7, 126.4, 126.2, 121.5,
118.1 (dt, 1JC-F 262.8, 
1JC-P 219.3), 64.9 (d, 
2JC-P 6.2), 16.4 (d,
3JC-P 5.7); δF (282 MHz, CDCl3) 108.3 (d, 
2JF-P 117.0); δP (121
MHz, CDCl3) 6.74 (t, 
2JP-F 117.0) [HRMS (CI, M  1) Found:
347.067978. Calc. for C15H18F2O3PS: 347.068236]; m/z (LCMS,
CI, 4.69 min) 364 (13%, M[NH4]), 347 (72, M  1), 327 (97),
299 (12), 235 (59), 187 (100).
4-(1-Benzofuran-2-yl)-1-[(diethoxyphosphoryl)diﬂuoromethyl]-
benzene 28h. Aryl triﬂate 6a and 1-benzofuran-2-ylboronic acid
were treated as described above for 1 hour. Following the usual
work up, puriﬁcation by ﬂash chromatography (20% ethyl acet-
ate in isohexane) aﬀorded an oﬀ white solid which crystallised
from ether–isohexane to aﬀord biaryl 28h (0.25 g, 66%) as white
plates, mp 104–106 C; Rf (40% ethyl acetate in isohexane) 0.33
(Found: C, 59.72; H, 4.88. C19H19F2O4P requires: C, 60.00; H,
5.04%); νmax(KBr)/cm
1 1269s, 1014s, 809m, 753m; δH (300
MHz, CDCl3) 7.93 (2 H, d, J 8.1, H-3, H-5), 7.69 (2 H, d, J 8.1,
H-2, H-6), 7.59 (1 H, d, J 7.0, H-7), 7.53 (1 H, d, J 8.1, H-4),
7.53–7.20 (2 H, m, H-4, H-6), 7.10 (1 H, s, H-3), 4.31–4.10
(4 H, m, -OCH2), 1.32 (6 H, t, 
3JH-H 7.0, -CH2CH3); δC (75 MHz,
CDCl3) 155.1, 154.6, 132.8, 132.3 (dt, 
2JC-F 22.0, 
2JC-P 13.6),
129.0, 126.8 (t, 3JC-F 5.6), 124.9, 124.8, 123.2, 121.3, 118.0 (dt,
1JC-F 262.8, 
1JC-P 218.7), 111.3, 102.9, 64.9 (d, 
2JC-P 6.8), 16.4 (d,
3JC-P 5.1); δF (282 MHz, CDCl3) 108.5 (d, 
2JF-P 115.4); δP (121
MHz, CDCl3) 6.60 (t, 
2JP-F 115.4) [HRMS (CI, M  1) Found:
381.106867. Calc. for C19H20F2O4P: 381.106729]; m/z (LCMS,
CI, 5.00 min) 398 (50%, M[NH4]), 381 (100, M  1), 361 (43).
Acknowledgements
The authors wish to thank the EU (ERASMUS studentship to
S. P.), EPSRC (Quota CASE studentship to H. J. E.) and Glaxo-
Wellcome for ﬁnancial support and Professor T. Yokomatsu of
Tokyo University, Japan for helpful discussions.
References
1 T. R. Burke and Z. Y. Zhang, Biopolymers, 1998, 47, 225.
2 T. K. Sawyer, Biopolymers, 1998, 47, 243.
3 C. García-Echeverría, P. Furet, B. Gay, H. Fretz, J. Rahuel,
J. Schoepfer and G. Caravatti, J. Med. Chem., 1998, 41, 1741.
4 J. Schoepfer, B. Gay, G. Caravatti, C. Garcia-Echeverria, H. Fretz,
J. Rahuel and P. Furet, Bioorg. Med. Chem. Lett., 1998, 8, 2865.
5 J. Schoepfer, H. Fretz, B. Gay, P. Furet, C. Garcia-Echeverria,
N. End and G. Caravatti, Bioorg. Med. Chem. Lett., 1999, 9, 221.
6 P. L. Beaulieu, D. R. Cameron, J. M. Ferland, J. Gauthier, E. Ghiro,
J. Gillard, V. Gorys, M. Poirier, J. Rancourt, D. Wernic, M.
LlinasBrunet, R. Betageri, M. Cardozo, E. R. Hickey, R. Ingraham,
S. Jakes, A. Kabcenell, T. Kirrane, S. Lukas, U. Patel, J. Proudfoot,
R. Sharma, L. Tong and N. Moss, J. Med. Chem., 1999, 42, 1757.
7 P. J. Hajduk, M.-M. Zhou and S. W. Fesik, Bioorg. Med. Chem.
Lett., 9, 2403.
8 E. A. Lunney, K. S. Para, J. R. Rubin, C. Humblet, J. H. Fergus,
J. S. Marks and T. K. Sawyer, J. Am. Chem. Soc., 1997, 119, 12471.
9 G. J. Pacofsky, K. Lackey, K. J. Alligood, J. Berman, P. S. Charifson,
R. M. Crosby, G. F. Dorsey, P. L. Feldman, T. M. Gilmer, C. W.
Hummel, S. R. Jordan, C. Mohr, L. M. Shewchuk, D. D. Sternbach
and M. Rodriguez, J. Med. Chem., 1998, 41, 1894.
10 P. S. Charifson, L. M. Shewchuk, W. Rocque, C. W. Hummel,
S. R. Jordan, C. Mohr, G. J. Pacofsky, M. R. Peel, M. Rodriguez,
D. D. Sternbach and T. G. Consler, Biochemistry, 1997, 36, 6283.
11 J. L. Buchanan, C. B. Vu, T. J. Merry, E. G. Corpuz, S. G.
Pradeepan, U. N. Mani, M. Yang, H. R. Plake, V. M. Varkhedkar,
B. A. Lynch, I. A. MacNeil, K. A. Loiacono, C. L. Tiong and
D. A. Holt, Bioorg. Med. Chem. Lett., 1999, 9, 2359.
12 J. L. Buchanan, R. S. Bohacek, G. P. Luke, M. Hatada, X. D. Lu,
D. C. Dalgarno, S. S. Narula, R. Yuan and D. A. Holt, Bioorg. Med.
Chem. Lett., 1999, 9, 2353.
13 J. M. Fu and A. L. Castelhano, Bioorg. Med. Chem. Lett., 1998, 8,
2813.
14 G. Waksman, S. E. Shoelson, N. Pant, D. Cowburn and J. Kuriyan,
Cell, 1993, 72, 779.
15 M. R. Groves, Z. J. Yao, P. P. Roller, T. R. Burke and D. Barford,
Biochemistry, 1998, 37, 17773.
16 H. Fretz, Tetrahedron, 1998, 54, 4849.
17 T. R. Burke, J. Luo, Z. J. Yao, Y. Gao, H. Zhao, G. W. A. Milne,
R. B. Guo, J. H. Voigt, C. R. King and D. J. Yang, Bioorg. Med.
Chem. Lett., 1999, 9, 347.
18 S. D. Taylor, C. C. Kotoris, A. N. Dinaut and M. J. Chen,
Tetrahedron, 1998, 54, 1691.
19 S. D. Taylor, C. C. Kotoris, A. N. Dinaut, Q. P. Wang,
C. Ramachandran and Z. Huang, Bioorg. Med. Chem., 1998, 6,
1457.
20 S. D. Taylor, A. N. Dinaut, A. N. Thadani and Z. Huang,
Tetrahedron Lett., 1996, 37, 8089.
21 K. Sato, R. Kawata, F. Ama, M. Omote, A. Ando and I. Kumadaki,
Chem. Pharm. Bull., 1999, 47, 1013.
22 T. R. Burke, B. Ye, M. Akamatsu, H. Ford, X. J. Yan, H. K. Kole,
G. Wolf, S. E. Shoelson and P. P. Roller, J. Med. Chem., 1996, 39,
1021.
23 P. P. Roller, L. Wu, Z. Y. Zhang and T. R. Burke, Bioorg. Med.
Chem. Lett., 1998, 8, 2149.
24 Z. G. Li, S. L. Yeo, C. J. Pallen and A. Ganesan, Bioorg. Med. Chem.
Lett., 1998, 8, 2443.
25 G. Bergnes, C. L. Gilliam, M. D. Boisclair, J. L. Blanchard,
K. V. Blake, D. M. Epstein and K. Pal, Bioorg. Med. Chem. Lett.,
1999, 9, 2849.
26 G. S. Cockerill, H. J. Easterﬁeld and J. M. Percy, Tetrahedron Lett.,
1999, 40, 2601.
27 T. Yokomatsu, T. Murano, I. Umesue, S. Soeda, H. Shimeno and
S. Shibuya, Bioorg. Med. Chem. Lett., 1999, 9, 529.
28 T. Yokomatsu, T. Murano, K. Suemune and S. Shibuya,
Tetrahedron, 1997, 53, 815.
29 A. Echavarren and J. K. Stille, J. Am. Chem. Soc., 1987, 109, 5478.
30 M. Rottlander and P. Knochel, J. Org. Chem., 1998, 63, 203.
31 Electron-poor aryl halides undergo oxidative addition to Pd(0)
complexes more readily than electron-rich counterparts; see A. F.
Litke and G. C. Fu, J. Org. Chem., 1999, 64, 10 and V. V. Grushin
and H. Alper, Chem. Rev., 1994, 94, 1047 for a recent example and
review respectively.
32 E. M. Kampouris, J. Chem. Soc., 1965, 2651; J. E. Baldwin, D. H. R.
Barton, I. Dainis and J. L. C. Pereira, J. Chem. Soc. C, 1968, 2283.
33 V. Farina, S. Kapadia, B. Krishnan, C. Wang and L. S. Liebeskind,
J. Org. Chem., 1994, 59, 5905.
34 Q.-Y. Chen and Z.-Y. Yang, Tetrahedron Lett., 1986, 27, 1171.
35 W.-C. Shieh and J. A. Carlson, J. Org. Chem., 1992, 57, 379.
36 N. A. Caplan, C. I. Pogson, D. J. Hayes and G. M. Blackburn,
J. Chem. Soc., Perkin Trans. 1, 2000, 421.
37 Vogel’s Textbook of Practical Organic Chemistry, Longman
Scientiﬁc and Technical, New York, 1989, 5th edn., p. 428.
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
tra
th
cl
yd
e 
on
 1
0 
Ju
ly
 2
01
2
Pu
bl
ish
ed
 o
n 
26
 Ju
ly
 2
00
0 
on
 h
ttp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/B
004
187
O
View Online
